The Jagsonpal Web site is not intended to give investment advice, promote the use of Jagsonpal products or provide information on which to base medical treatment. If you have questions regarding any Jagsonpal products, please consult your health care provider. We cannot answer product-related questions through this Web site.
| INDIA |
Jagsonpal Pharmaceuticals Limited
T-210 J, Shahpur Jat,
New Delhi - 110 049
India
Ph: +91 11 2649 4519
Fax: 26494708 / 26498341
india@jagsonpalpharma.com
|
| USA |
Jagsonpal Pharmaceuticals Limited
303 5th Avenue Suite #506
New York, NY - 10016
USA
Ph: 646-415-8744
americas@jagsonpalpharma.com
|
| BELARUS |
Jagsonpal Pharmaceuticals Limited
55, Kiseleva Str.
Minsk - 220002
Belarus
Mobile: +375 29 95 000
24
Res: +375 17 29
455 29
OFF tel/fax: +375 17 33 402 95
belarus@jagsonpalpharma.com
|
| POLAND |
Kind Attn.: Mr. Andrzej Gerejczyk
NTC Andar
4, Kierbedzia Street
00-728 Warszawa
Poland
Tel.: + 0048 22 331 67 89
biuro@ntcandar.com.pl
|
| UKRAINE |
Mobile: +380 95 695 80 50
Tel/fax: +380 44 407 12 10
ukraine@jagsonpalpharma.com |
Note: This Web site is not for medical emergencies. Please do not use this Web site for Adverse Event Reporting. If you are a physician, follow the procedures required by your country's regulations. |